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Abstract
Purpose The growing popularity and acceptance of inte-
grative medicine is evident both among patients and among
the oncologists treating them. As little data are available
regarding health-care professionals’ knowledge, attitudes,
and practices relating to the topic, a nationwide online
survey was designed.
Methods Over a period of 11 weeks (from July 15 to
September 30, 2014) a self-administered, 17-item online
survey was sent to all 676 members of the Research Group
on Gynecological Oncology (Arbeitsgemeinschaft
Gyna¨kologische Onkologie) in the German Cancer Society.
The questionnaire items addressed the use of integrative
therapy methods, fields of indications for them, advice
services provided, level of specific qualifications, and other
topics.
Results Of the 104 respondents (15.4%) using integrative
medicine, 93% reported that integrative therapy was
offered to breast cancer patients. The second most frequent
type of tumor in connection with which integrative therapy
methods were recommended was ovarian cancer, at 80% of
the participants using integrative medicine. Exercise,
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nutritional therapy, dietary supplements, herbal medicines,
and acupuncture were the methods the patients were most
commonly advised to use.
Conclusion There is considerable interest in integrative
medicine among gynecological oncologists, but integrative
therapy approaches are at present poorly implemented in
routine clinical work. Furthermore there is a lack of
specific training. Whether future efforts should focus on
extending counseling services on integrative medicine
approaches in gynecologic oncology or not, have to be
discussed. Evidence-based training on integrative medicine
should be implemented in order to safely guide patients in
their wish to do something by themselves.
Keywords Integrative medicine  Complementary
medicine  Gynecologic oncology  Breast cancer 
Oncologists’ attitudes  Survey
Introduction
Complementary and integrative medicine is becoming
increasingly popular with gynecological patients. At pre-
sent, 38–60% of all cancer patients in Western industrial-
ized countries take advantage of complementary and
alternative medicine (CAM) during the course of their
disease and to support their treatment [1]. In the case of
breast cancer, the figure is even as high as 90% [2, 3].
Breast cancer patients and gynecological cancer patients in
particular, are the group with the highest percentage usage
of integrative methods [1, 4, 5]. Women’s willingness to
take the initiative in relation to these treatments is gener-
ally greater than men’s, and women are highly motivated in
relation to their disease, with good compliance and con-
siderable perseverance.
The Academic Consortium for Integrative Medicine
and Health in the USA has described integrative medicine
as follows: ‘‘Integrative medicine and health reaffirms the
importance of the relationship between practitioner and
patient, focuses on the whole person, is informed by
evidence, and makes use of all appropriate therapeutic and
lifestyle approaches, healthcare professionals and disci-
plines to achieve optimal health and healing’’ [6]. In this
approach, complementary methods that aim to contribute
to holistic care are integrated into present-day medical
practices. The complementary procedures—for the most
part based on experience—are to be regarded as a sup-
plement to the current scientific, evidence-based medical
system, not as a substitute for it. We classify the inte-
grative medicine into five sub-groups: whole medical
systems (e.g., homeopathy, naturopathic treatments,
Ayurveda), mind/body-based interventions (e.g., medita-
tion, chi gong, yoga), body-based therapies (e.g.,
massages, sports, chiropractic), biological-based therapies
(e.g., phytotherapy, vitamins, enzymes) and energy-based
methods (e.g., electrotherapy, hyperthermia, ultrasound
therapy). Common methods in integrative medicine
include homeopathy, anthroposophic medicine, in partic-
ular mistletoe therapy, classic naturopathic treatment,
phytotherapy, traditional Chinese medicine (TCM)
including acupuncture, sports, nutritional approaches,
vitamin products, mineral nutrients, dietary supplements
and relaxation therapies [7].
Previous studies on CAM have mainly addressed the
frequency and methods involved in the complementary
therapies used, as well as the patients’ motivation, objec-
tives, information sources, and characteristics [8–12]. Most
of the breast cancer patients show high interest in CAM
[13, 14]. However, little is known about the acceptance and
use of integrative medicine by gynecological oncologists in
Germany. At the moment the overall qualified access to
counseling on integrative medicine is not available. There
is a lack of data with regard to the provision of information,
competences, qualifications, and structures. Little is also
known about the concrete ways in which integrative
medical therapies are implemented and used in the field of
gynecology.
The present study was therefore carried out to evaluate
and examine the degree of acceptance, usage, and imple-
mentation of integrative medicine among gynecological
oncologists in Germany.
Materials and methods
A self-administered 17-item online survey was sent
between July 15, 2014 and September 30, 2014 to all 676
members of the Research Group on Gynecological
Oncology of the German Cancer Society (Arbeitsgemein-
schaft Gyna¨kologische Onkologie, AGO).
The survey was developed and distributed by the
Research Group on Integrative Medicine (AG IMed),
which was founded on June 28, 2013. This group of
gynecological oncologists focuses on the clinical, scien-
tific, and organizational aspects of integrative medicine in
oncology. It supports scientific research and cooperation in
the field of integrative medicine and also encourages the
implementation of approved integrative therapy approa-
ches and regular consultation hours for the purpose, in
order to integrate these into standard oncologic care.
For the validation, the questionnaire of the survey was
tested in the AG IMed Research Group on Integrative
Medicine, consisting of 20 members, and evaluated using a
specially developed assessment sheet. After the validation,
the questionnaire was modified with a view to improving
comprehension, functionality and expenditure of time.
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The online survey was sent to all 676 members of the
AGO via e-mail. Participation was voluntary and anony-
mous. The first e-mail and call for participation was
launched in July 2014, and a reminder e-mail was sent in
September to members who had not yet responded, until
the original deadline had passed.
The survey contained 17 questions including demo-
graphic data and items on the use of integrative therapy
methods, fields of indications, consulting services, level of
specific qualifications, and other topics. There are no
standardized questionnaires for professionals on this topic.
So we had to develop our own questionnaire for this sur-
vey. The time required to respond to it was approximately
10 min.
Data were analyzed using IBM SPSS Statistics, version
24 (IBM Corp., Armonk, New York, USA). Statistical
evaluation consisted of descriptive analysis. Total amounts
and percentages were calculated.
Results
In all, 104 of the 676 AGO members participated in the
survey (32.7% women, 67.3% men). This represents a
response rate of 15.4%. The respondents’ median age was
47 years (range 30–71 years). The majority (56.7%) had
medical degrees (M.D./Dr. med.), and 35.6% of the
responding physicians also had higher qualifications, such
as associate professor or professor. Seventy-six percent of
the participating members were working at certified breast
cancer centers and 56.7% of them at certified gynecologi-
cal oncology centers. This is consistent with the demo-
graphic structure of the AGO. The percentage of men with
66% is almost twice as high as that of women’s with 34%.
54.1% of the AGO members bear the title M.D., 29.3%
professor and 9.2% associate professor. There are 77.4%
full members and 19% associated members. The age ranges
from 26 to 86 years with a mean age of 51 years.
The form of integrative therapy method most commonly
recommended amongst the participants was regular phys-
ical exercise, followed by nutritional counseling and advice
on dietary supplements (Fig. 1). The main indications were
fatigue, nausea, depression, menopausal symptoms, and
sleeping disorders (Table 1). When they were asked at
which point of time they provided advice about integrative
therapy, most of the oncologists indicated that it was dur-
ing follow-up care for their patients. With regard to the
treatment phase, counseling on integrative medicine was
most frequently provided during chemotherapy (Fig. 2).
Most of the physicians surveyed and using integrative
medicine (93%) reported that they used integrative therapy
methods with breast cancer patients. The second largest
patient group to whom integrative therapies were suggested
consisted of ovarian cancer patients, at 80% of the partic-
ipants using integrative medicine (Fig. 3). This is not in
contrast to their statement that two-thirds stated that inte-
grative medicine is not routinely implemented in the
therapy concept, because implementation in the routine is
still more than a recommendation from time to time, for
example consultations of integrative medicine or profes-
sional counseling on CAM.
Counseling on applicable integrative therapies is mainly
provided by the physicians themselves (93%), and sec-
ondly by dietitians, collaborating partners (e.g., specialized
centers, nonmedical practitioners, etc.), and breast care
nurses (Table 2). The counseling was performed according
to the differences in the professional qualification. The
additional qualifications most often held by those providing
advice were in naturopathy (48.6%), followed by nutri-
tional medicine (30.5%) and acupuncture (29.2%). All of
these are qualifications that are officially recognized by the
relevant regional medical councils. Other areas in which
qualifications were held were homeopathy, traditional
Chinese medicine (TCM), phytotherapy, etc. Table 3 lists
the proportions of advisers holding the different types of
qualifications.
Two-thirds of the gynecologic oncologists surveyed
stated that integrative therapy concepts were not imple-
mented in routine clinical work, but 64.7% of them indi-
cated that they were planning to do so. The main reasons
given in the further comments section for not implementing
integrative medicine in their hospitals were staff shortages,
a lack of specific knowledge and qualifications, as well as a
lack of scientific evidence on the efficacy of the therapies
concerned. Around half of the physicians (55.5%) stated
that integrative therapy methods are not reimbursed and are
therefore not profitable for the hospitals.
Discussion
Patients with breast cancer and gynecological cancer are
known to be one of the patient groups who make use of
integrative medicine most often [15]. These patients wish
to receive advice from their oncologists not only about
conventional medicine, but also about complementary
therapy methods during and after the disease [13, 16].
More and more oncologists in Germany are beginning to
appreciate this need and the importance of offering pro-
fessional advice regarding integrative medicine.
As the survey shows, however, there is still a lack of
widespread implementation of integrative therapy approa-
ches in routine clinical work. Only one-third of the
oncologists who responded had routinely offered comple-
mentary counseling to their patients. The main reasons for
this are a lack of knowledge and professional training. This
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finding is consistent with the report by Muecke et al., who
showed that education and training are the most essential
requirements for physicians to enable them to implement
CAM methods [17]. Other national and international
studies have also confirmed the finding that there is gen-
erally a high level of interest in integrative therapy
approaches amongst physicians, but that specific training in
CAM methods is lacking [17–22]. Comparison with
existing data is difficult, as the studies are not mainly
aimed at oncologists, but rather at physicians in general, so
that the groups of patients involved differ. Conrad et al.
conducted a large survey on professionals in palliative care
regarding attitudes toward CAM. Acceptance of CAM was
high (92% for complementary medicine). Only 21% think
themselves adequately informed [23]. Another study
evaluated the attitude of employees of a university clinic to
complementary and alternative medicine in oncology is
also in line with our results. Most participants were inter-
ested in complementary medicine and a substantial part
would use CAM. But they were not trained on this topic
[24]. In addition, most published data on complementary
therapy methods have concentrated on the patient’s point
of view, mainly examining their acceptance and use of
integrative medicine.
With regard to the patient groups identified in the pre-
sent survey, the largest group to whom the oncologists
recommended complementary therapies was breast cancer
patients—a finding that is consistent with earlier studies
[5, 25–27]. This again underlines the importance and need
for gynecologic oncologists to acquire knowledge about
verified integrative therapy approaches in order to offer
counseling in this field.
The findings should be evaluated in light of the limita-
tions of the study. The national survey was only addressed
to AGO members and not to other hospitals or oncologists
who also counsel breast cancer and gynecological cancer
patients in Germany. In addition, there might have been
some overlap among the responses if several AGO
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members from a single hospital were responding. Finally,
the response rate and thus the final number of participants
(n = 104) were quite low.
In view of the results of this survey and the existing
data, future efforts should focus firstly on improving
acceptance, and secondly on extending counseling services
for integrative medicine approaches in gynecologic
oncology. To ensure this, the existing additional training
courses organized by the various regional medical councils
and specialized research groups should be taken advantage
of more frequently. The aim should be to provide more
gynecologic oncologists in hospitals and oncologists’
offices with sound expertise, to enable them to provide
guidance for patients. Particularly during the last few years,
there has been increasing research and there is conse-
quently growing evidence for integrative medicine in
oncology. Although further research is still needed,
oncologists can provide their patients with evidence-based
treatment approaches and recommendations.
Evidence-based training on integrative medicine should
be implemented in order to safely guide patients in their
wish to do something by themselves. The educated
Table 1 The main indications for using integrative therapies; n = 82
(n = 22 not applicable); multiple responses were allowed
Indication n %
Fatigue 65 79.3
Nausea and vomiting 61 74.4
Depression 59 72.0
Menopausal symptoms 59 72.0
Sleeping disorders 59 72.0
Loss of appetite 58 70.7
Joint pain 44 53.7
Polyneuropathy 43 52.4
Abdominal discomfort 42 51.2
Cognitive impairments 39 47.6
Mucositis 35 42.7
Hand–foot syndrome 34 41.5
Pain 34 41.5
Radiation-induced dermatitis 30 36.6
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attending physicians could better raise the topic of inte-
grative medicine and encourage evidence-based comple-
mentary treatments for ensuring individualized, holistic,
and patient-centered care.
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